Kenya's Esther Gitahi handed four-year ban after positive EPO test
Athletics
By
Robert Abong'o
| Oct 28, 2025
26-year-old Kenyan middle-distance runner Esther Gitahi has been banned from athletics for four years after testing positive for erythropoietin (EPO), the Athletics Integrity Unit (AIU) announced on Monday.
The Disciplinary Tribunal ruled the ban retroactive to August 6, 2024, following the athlete’s adverse analytical finding and subsequent proceedings.
Gitahi’s positive result came from a urine sample she provided at the B.A.A. 5K in Boston, Massachusetts, on April 13, 2024. Laboratory analysis detected EPO, a substance that stimulates red blood cell production and can boost endurance, and is prohibited under World Anti-Doping Agency (WADA) rules.
The AIU determined that she both possessed and used the substance, violating regulations.
The Disciplinary Tribunal has banned Esther Gitahi (Kenya) for 4 years from 6 August 2024 for Presence/Use of a Prohibited Substance (EPO). DQ results from 1 July 2023
Details here: https://t.co/UN2QCGb145 pic.twitter.com/BhKjVCzeQRREAD MORE
State's affordable housing project: Why Kenyans are sceptical
Government backs TouristTap in drive to formalise revenues
Why Kenya must rethink how food systems are delivered
Regulators tighten grip on predatory lending practices
Nairobi set for new Sh672m urban greening initiative
Mortgages fall short in solving Kenya's housing crisis
State banks on sensitisation forums to unlock Kenya's Pig sector as pork demand rises
IMF to Ruto: Stop lying on hidden debt
Idea behind Local Content Bill good, but challenges lie ahead
After clinching Sh377b in trade deals, State now faces harder part
— Athletics Integrity Unit (@aiu_athletics) October 27, 2025
After the Adverse Analytical Finding was communicated on August 6, 2024, Gitahi faced provisional suspension. She waived the right to have the B-sample tested, and the hearing proceeded with the available evidence. Gitahi admitted to using injections but contended that she did not realise they contained a banned substance.
In her statement, Gitahi explained that the injections were prescribed to manage thalassemia, a blood disorder she suspected she had. She said she sought medical advice from a Kenyan clinic in 2022 after experiencing fatigue and joint pain. Reports indicate she self-administered eight doses over about 10 months, with the positive test arising after the second round in early 2024.
The four-year sanction ends in 2028, barring any potential appeals or procedural outcomes.